Kazutaka Oda, Kazuaki Matsumoto, Kensuke Shoji, Akari Shigemi, Hideki Kawamura, Yoshiko Takahashi, Tomomi Katanoda, Yumi Hashiguchi, Hirofumi Jono, Hideyuki Saito, et al. Validation and development of population pharmacokinetic model of vancomycin using a real-world database from a nationwide free web application. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024
Kazutaka Oda, Hirofumi Jono, Hidenobu Kamohara, Hideyuki Saito. Population Pharmacokinetic Modeling of Unbound Meropenem in Patients Undergoing Continuous Renal Replacement Therapy: An Observational Cohort Study. Therapeutic Drug Monitoring. 2024
Tomoyuki Yamada, Kazutaka Oda, Masami Nishihara, Masashi Neo. A simulation study on model-informed precision dosing of amikacin for achieving target area under the concentration-time curve. British Journal of Clinical Pharmacology. 2024. 90. 4. 1173-1182
Hajime Nakashima, Motoyasu Miyazaki, Tsuneo Kuwamura, Kazutaka Oda, Yumi Haga, Osamu Imakyure. Relationship between Target Time above Minimum Inhibitory Concentration Achievement Rate of Meropenem Using Monte Carlo Simulation and In-Hospital Survival in Patients with Pseudomonas aeruginosa Bacteremia. Antibiotics. 2024. 13. 3
Naoko Kanazawa, Akari Shigemi, Nao Amadatsu, Kotaro Arimura, Shohei Shimono, Kazutaka Oda, Victor Tuan Giam Chuang, Kazuaki Matsumoto, Hideki Kawamura, Hideyuki Terazono. A cohort study of the risk factors and the target AUC to avoid vancomycin-associated acute kidney injury in pediatric patients. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2023